Literature DB >> 22701893

Sorcin, a potential therapeutic target for reversing multidrug resistance in cancer.

Bei-Bei Zheng1, Peng Zhang, Wei-Wei Jia, Lu-Gang Yu, Xiu-Li Guo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22701893     DOI： 10.1007/s13105-011-0140-0

Source DB:  PubMed          Journal:  J Physiol Biochem        ISSN： 1138-7548            Impact factor:   4.158


× No keyword cloud information.
  51 in total

1.  The PEF family proteins sorcin and grancalcin interact in vivo and in vitro.

Authors:  Christian Hansen; Svetlana Tarabykina; Jonas M la Cour; Karsten Lollike; Martin W Berchtold
Journal:  FEBS Lett       Date:  2003-06-19       Impact factor: 4.124

2.  Knock-down of sorcin induces up-regulation of MDR1 in HeLa cells.

Authors:  Megumi Kawakami; Tsutomu Nakamura; Noboru Okamura; Chiho Komoto; Svetlana Markova; Hironao Kobayashi; Naofumi Hashimoto; Katsuhiko Okumura; Toshiyuki Sakaeda
Journal:  Biol Pharm Bull       Date:  2007-06       Impact factor: 2.233

3.  Genes amplified and overexpressed in human multidrug-resistant cell lines.

Authors:  A M Van der Bliek; F Baas; T Van der Velde-Koerts; J L Biedler; M B Meyers; R F Ozols; T C Hamilton; H Joenje; P Borst
Journal:  Cancer Res       Date:  1988-11-01       Impact factor: 12.701

4.  Presenilin 2 interacts with sorcin, a modulator of the ryanodine receptor.

Authors:  E Pack-Chung; M B Meyers; W P Pettingell; R D Moir; A M Brownawell; I Cheng; R E Tanzi; T W Kim
Journal:  J Biol Chem       Date:  2000-05-12       Impact factor: 5.157

5.  Sorcin, an important gene associated with multidrug-resistance in human leukemia cells.

Authors:  Yuan Zhou; Yuanfu Xu; Yaohong Tan; Jing Qi; Ying Xiao; Chunzheng Yang; Zhenping Zhu; Dongsheng Xiong
Journal:  Leuk Res       Date:  2005-10-06       Impact factor: 3.156

Review 6.  Regulation of Cav1.2 current: interaction with intracellular molecules.

Authors:  Takeshi Kobayashi; Yoichi Yamada; Mitsuhiro Fukao; Masaaki Tsutsuura; Noritsugu Tohse
Journal:  J Pharmacol Sci       Date:  2007-04-04       Impact factor: 3.337

7.  Transgenic mice with cardiac-specific expression of activating transcription factor 3, a stress-inducible gene, have conduction abnormalities and contractile dysfunction.

Authors:  Y Okamoto; A Chaves; J Chen; R Kelley; K Jones; H G Weed; K L Gardner; L Gangi; M Yamaguchi; W Klomkleaw; T Nakayama; R L Hamlin; C Carnes; R Altschuld; J Bauer; T Hai
Journal:  Am J Pathol       Date:  2001-08       Impact factor: 4.307

8.  The sorcin-annexin VII calcium-dependent interaction requires the sorcin N-terminal domain.

Authors:  D Verzili; C Zamparelli; B Mattei; A A Noegel; E Chiancone
Journal:  FEBS Lett       Date:  2000-04-14       Impact factor: 4.124

Review 9.  Targeting multidrug resistance in cancer.

Authors:  Gergely Szakács; Jill K Paterson; Joseph A Ludwig; Catherine Booth-Genthe; Michael M Gottesman
Journal:  Nat Rev Drug Discov       Date:  2006-03       Impact factor: 84.694

10.  A 22-kd protein (sorcin/V19) encoded by an amplified gene in multidrug-resistant cells, is homologous to the calcium-binding light chain of calpain.

Authors:  A M Van der Bliek; M B Meyers; J L Biedler; E Hes; P Borst
Journal:  EMBO J       Date:  1986-12-01       Impact factor: 11.598
View more
  4 in total

1.  shRNA-mediated silencing of sorcin increases drug chemosensitivity in myeloma KM3/DDP and U266/ADM cell lines.

Authors:  Ping Xu; Yong-Fang Jiang; Jing-Hua Wang
Journal:  Int J Clin Exp Pathol       Date:  2015-03-01

2.  Resistance to paclitxel in breast carcinoma cells requires a quality control of mitochondrial antiapoptotic proteins by TRAP1.

Authors:  Francesca Maddalena; Lorenza Sisinni; Giacomo Lettini; Valentina Condelli; Danilo Swann Matassa; Annamaria Piscazzi; Maria Rosaria Amoroso; Giuseppe La Torre; Franca Esposito; Matteo Landriscina
Journal:  Mol Oncol       Date:  2013-05-02       Impact factor: 6.603

3.  Binding of doxorubicin to Sorcin impairs cell death and increases drug resistance in cancer cells.

Authors:  Ilaria Genovese; Annarita Fiorillo; Andrea Ilari; Silvia Masciarelli; Francesco Fazi; Gianni Colotti
Journal:  Cell Death Dis       Date:  2017-07-20       Impact factor: 8.469

4.  Broad regulation of gene isoform expression by Wnt signaling in cancer.

Authors:  Muhammad Idris; Nathan Harmston; Enrico Petretto; Babita Madan; David M Virshup
Journal:  RNA       Date:  2019-09-10       Impact factor: 4.942
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.